268 related articles for article (PubMed ID: 35830291)
1. Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.
Ye YP; Zhao H; Kang T; Zhao LH; Li N; Chen J; Peng XX
Chron Respir Dis; 2022; 19():14799731221108516. PubMed ID: 35830291
[TBL] [Abstract][Full Text] [Related]
2. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
[TBL] [Abstract][Full Text] [Related]
3. Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational study.
Titova E; Christensen A; Henriksen AH; Steinshamn S; Åsberg A
Chron Respir Dis; 2019; 16():1479972318769762. PubMed ID: 29848051
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of serum procalcitonin for non-invasive positive pressure ventilation in the patients with acute exacerbation of chronic obstructive pulmonary disease.
Liu L; Luan Y; Xiao L; Wang N; Wang J; Cui Z
Medicine (Baltimore); 2021 Apr; 100(16):e25547. PubMed ID: 33879703
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin (PCT) Improves the Accuracy and Sensitivity of Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation (DECAF) Score in Predicting AECOPD Patients Admission to ICU.
Chen Y; Li LIQ; Ge YL; Hu XY; Zhang Q; Zhang HF; Li WQ; Zhang S; Zhu XY; Zhang JB
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162862
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Song W; Wang Y; Tian F; Ge L; Shang X; Zeng Q; Feng N; Fan J; Wang J; Ma X
Dis Markers; 2021; 2021():8879401. PubMed ID: 33791046
[TBL] [Abstract][Full Text] [Related]
7. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin, C-reactive protein, PaCO2, and noninvasive mechanical ventilation failure in chronic obstructive pulmonary disease exacerbation.
Wang J; Shang H; Yang X; Guo S; Cui Z
Medicine (Baltimore); 2019 Apr; 98(17):e15171. PubMed ID: 31027061
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of serum procalcitonin and hypersensitive C-reactive protein levels in patients with acute cerebral infarction complicated with infection].
Wang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):962-966. PubMed ID: 31537220
[TBL] [Abstract][Full Text] [Related]
10. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
[No Abstract] [Full Text] [Related]
11. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
Bafadhel M; Clark TW; Reid C; Medina MJ; Batham S; Barer MR; Nicholson KG; Brightling CE
Chest; 2011 Jun; 139(6):1410-1418. PubMed ID: 21030489
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of CRP, PCT and ESR on Piperacillin-Tazobactam in Treating Chronic Obstructive Pulmonary Disease with Pneumonia.
Xu B; Han L
Clin Lab; 2023 Apr; 69(4):. PubMed ID: 37057952
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin: Is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation?
Pazarli AC; Koseoglu HI; Doruk S; Sahin S; Etikan I; Celikel S; Berktas B
J Res Med Sci; 2012 Nov; 17(11):1047-51. PubMed ID: 23833579
[TBL] [Abstract][Full Text] [Related]
14. nCD64 index as a prognostic biomarker for mortality in acute exacerbation of chronic obstructive pulmonary disease.
Xu N; Chen J; Chang X; Zhang J; Liu Q; Li A; Lin D
Ann Saudi Med; 2016; 36(1):37-41. PubMed ID: 26922686
[TBL] [Abstract][Full Text] [Related]
15. D-Dimer and Procalcitonin Improve the Sensitivity of BAP-65 Score in Predicting AECOPD Patients Admission to ICU.
Zhang Q; Liu JX; Bai JS; Wang JM; Fu AS; Liu RX; Zhou XY; Gao S; Chen QC; Zhang JB; Ge YL
Clin Lab; 2023 Feb; 69(2):. PubMed ID: 36787555
[TBL] [Abstract][Full Text] [Related]
16. Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU.
Daubin C; Fournel F; Thiollière F; Daviaud F; Ramakers M; Polito A; Flocard B; Valette X; Du Cheyron D; Terzi N; Fartoukh M; Allouche S; Parienti JJ;
Ann Intensive Care; 2021 Mar; 11(1):39. PubMed ID: 33675432
[TBL] [Abstract][Full Text] [Related]
17. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections.
Duan S; Gu X; Fan G; Zhou F; Zhu G; Cao B
BMC Pulm Med; 2021 Sep; 21(1):308. PubMed ID: 34583675
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil CD64 Expression as a Diagnostic Marker in Patients Hospitalized with Exacerbations of COPD: A Prospective Observational Study.
Titova E; Aune MW; Fonn K; Henriksen AH; Åsberg A
Lung; 2015 Oct; 193(5):717-24. PubMed ID: 26174093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
